Von Willebrand Factor and Protein C Ratio in Graft Function After Liver Transplant
NCT ID: NCT04324255
Last Updated: 2020-03-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
1199 participants
OBSERVATIONAL
2014-01-01
2020-04-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Thrombin Generation in Liver Transplant Surgery
NCT04762550
The Perioperative Value of Platelet Counts in Predicting Outcome After Liver Transplantation
NCT01711957
Alterations in Coagulation Factor Levels in Patients With End Stage Liver Disease
NCT06014320
Fibrinogen and Intraoperative Bleeding in Liver Transplant
NCT04925843
Fibrinogen in Liver Transplant
NCT07265843
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Low ratio
Liver recipient with low preoperative von Willbrand factor-to-protein C ratio
LT
Liver transplantation
High ratio
Liver recipient with high preoperative von Willbrand factor-to-protein C ratio
LT
Liver transplantation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
LT
Liver transplantation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Asan Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hyemee Kwon
Doctor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Asan Medical center
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2016-0031
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.